Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Natriuretic peptides in heart failure: where we are, where we are going
A Palazzuoli, G Antonelli, I Quatrini, R Nuti - Internal and emergency …, 2011 - Springer
Tremendous advances have been made in understanding the pathophysiology and
treatment of congestive heart failure (CHF). However, diagnosis still remains difficult, even …
treatment of congestive heart failure (CHF). However, diagnosis still remains difficult, even …
[HTML][HTML] Brain natriuretic peptide measurement in pulmonary medicine
Serum levels of natriuretic peptides are well established as important biomarkers in patients
with cardiac disease. Less attention has been placed on the role of natriuretic peptides in …
with cardiac disease. Less attention has been placed on the role of natriuretic peptides in …
[PDF][PDF] Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Supervised versus unsupervised pulmonary rehabilitation in patients with pulmonary embolism: a valuable alternative in COVID era
VT Stavrou, M Griziotis, GD Vavougios… - Journal of Functional …, 2021 - mdpi.com
The aim of our study was to assess the effect of 8 weeks of pulmonary rehabilitation (PR) in
patients with pulmonary embolism (PE) during unsupervised PR (unSPRgroup) versus …
patients with pulmonary embolism (PE) during unsupervised PR (unSPRgroup) versus …
Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism
A Naito, N Tanabe, T Jujo, A Shigeta, T Sugiura… - PLoS …, 2014 - journals.plos.org
Background Pentraxin3 (PTX3) is a protein, which has multifaceted effects on innate
immunity, angiogenesis, and vascular remodeling then could be a disease marker of acute …
immunity, angiogenesis, and vascular remodeling then could be a disease marker of acute …
Diagnostic utility of NT-proBNP and ANP in a canine model of chronic embolic pulmonary hypertension
Y Hori, T Uchide, R Saitoh, D Thoei, M Uchida… - The Veterinary …, 2012 - Elsevier
The information needed to diagnose pulmonary arterial hypertension (PAH) in dogs based
on N-terminal pro B-type natriuretic peptide (NT-proBNP) and atrial natriuretic peptide (ANP) …
on N-terminal pro B-type natriuretic peptide (NT-proBNP) and atrial natriuretic peptide (ANP) …
Prevalence of pulmonary hypertension in hereditary spherocytosis.
SE Crary, C Ramaciotti… - American Journal of …, 2011 - europepmc.org
Vascular complications, including pulmonary hypertension (PH), have been reported to
occur following splenectomy for various disorders, including hereditary spherocytosis (HS) …
occur following splenectomy for various disorders, including hereditary spherocytosis (HS) …
脑利钠肽BNP 的临床应用进展
杨欣， 任斌辉， 许林 - 现代生物医学进展, 2013 - cqvip.com
脑利钠肽(BNP) 是利钠肽系统中的重要成员之一. BNP 是一种包含了32 个氨基酸的多肽,
于1998 年被日本学者从猪脑中发现并提取出来. 它主要由心室肌细胞受压分泌 …
于1998 年被日本学者从猪脑中发现并提取出来. 它主要由心室肌细胞受压分泌 …
Primary antiphospholipid syndrome and pulmonary hypertension
AE Mirrakhimov, NS Hill - Current Pharmaceutical Design, 2014 - ingentaconnect.com
Primary antiphospholipid syndrome (APS) is a disease characterized by the presence of
autoantibodies reacting with proteins bound to phospholipids, leading to thrombosis and …
autoantibodies reacting with proteins bound to phospholipids, leading to thrombosis and …